Federated Hermes’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.9K Buy
12,222
+2,671
+28% +$8.54K ﹤0.01% 1693
2025
Q4
$26.1K Sell
9,551
-5,560
-37% -$12.9K ﹤0.01% 1724
2025
Q3
$32.8K Buy
15,111
+6,095
+68% +$14.4K ﹤0.01% 1741
2025
Q2
$15.5K Buy
+9,016
New +$22.4K ﹤0.01% 1750
2023
Q1
Sell
-10,669
Closed -$68.2K 2187
2022
Q4
$68.2K Buy
+10,669
New +$83.3K ﹤0.01% 1682
2022
Q2
Sell
-15,768
Closed -$263K 2222
2022
Q1
$263K Buy
+15,768
New +$244K ﹤0.01% 1555
2021
Q2
Sell
-27,017
Closed -$855K 2269
2021
Q1
$855K Sell
27,017
-3,948
-13% -$164K ﹤0.01% 1431
2020
Q4
$1.44M Buy
30,965
+14,597
+89% +$580K ﹤0.01% 1187
2020
Q3
$539K Sell
16,368
-29
-0.2% -$889 ﹤0.01% 1459
2020
Q2
$450K Buy
+16,397
New +$539K ﹤0.01% 1498
2020
Q1
Sell
-150
Closed -$4K 2294
2019
Q4
$4K Sell
150
-44,277
-100% -$1.01M ﹤0.01% 1979
2019
Q3
$809K Sell
44,427
-298,456
-87% -$6.6M ﹤0.01% 1350
2019
Q2
$8.41M Buy
342,883
+342,421
+74,117% +$5.16M 0.02% 638
2019
Q1
$4K Sell
462
-43
-9% -$418 ﹤0.01% 1999
2018
Q4
$4K Sell
505
-31,495
-98% -$304K ﹤0.01% 2010
2018
Q3
$360K Sell
32,000
-57,911
-64% -$822K ﹤0.01% 1526
2018
Q2
$1.15M Buy
89,911
+23,659
+36% +$346K ﹤0.01% 1239
2018
Q1
$1.12M Buy
66,252
+65,789
+14,209% +$996K ﹤0.01% 1196
2017
Q4
$4K Buy
+463
New +$3.72K ﹤0.01% 2015
2016
Q4
Sell
-1,221
Closed -$10K 2143
2016
Q3
$10K Buy
+1,221
New +$10.3K ﹤0.01% 1819
2015
Q4
Sell
-60,000
Closed -$346K 2116
2015
Q3
$346K Hold
60,000
﹤0.01% 1381
2015
Q2
$550K Buy
+60,000
New +$670K ﹤0.01% 1307

Other funds holding IOVA